These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2934464)

  • 1. Insulin resistance and secretion in polycystic ovarian disease.
    Bruno B; Poccia G; Fabbrini A
    J Endocrinol Invest; 1985 Oct; 8(5):443-8. PubMed ID: 2934464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease.
    Jialal I; Naiker P; Reddi K; Moodley J; Joubert SM
    J Clin Endocrinol Metab; 1987 May; 64(5):1066-9. PubMed ID: 2951393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in nonobese patients with polycystic ovarian disease.
    Chang RJ; Nakamura RM; Judd HL; Kaplan SA
    J Clin Endocrinol Metab; 1983 Aug; 57(2):356-9. PubMed ID: 6223044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent.
    Seyam E; Hefzy E
    Gynecol Endocrinol; 2018 Jun; 34(6):481-488. PubMed ID: 29254383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
    Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
    Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.
    Nestler JE; Clore JN; Strauss JF; Blackard WG
    J Clin Endocrinol Metab; 1987 Jan; 64(1):180-4. PubMed ID: 2946716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A; Noyan V; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in nonobese patients with polycystic ovary syndrome.
    Toprak S; Yönem A; Cakir B; Güler S; Azal O; Ozata M; Corakçi A
    Horm Res; 2001; 55(2):65-70. PubMed ID: 11509861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
    Anttila L; Ding YQ; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
    Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.
    Anttila L; Koskinen P; Jaatinen TA; Erkkola R; Irjala K; Ruutiainen K
    Hum Reprod; 1993 Aug; 8(8):1179-83. PubMed ID: 8408513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
    Lobo RA; Kletzky OA; Campeau JD; diZerega GS
    Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.